In this episode of Stem Cell Genius, Samantha Brechner, President of R3 Stem Cell, sits down with the visionary Founder and CEO of R3 Stem Cell, Dr. David Greene, to explore one of the most important questions in regenerative medicine — How do stem cells differ in the United States compared to international use? Together, they dive into the contrasts in regulations, sources, and applications of stem cells across borders. From the highly regulated environment in the U.S. to the broader, less r...
All content for Stem Cell Genius is the property of David Greene and Samantha Brechner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Stem Cell Genius, Samantha Brechner, President of R3 Stem Cell, sits down with the visionary Founder and CEO of R3 Stem Cell, Dr. David Greene, to explore one of the most important questions in regenerative medicine — How do stem cells differ in the United States compared to international use? Together, they dive into the contrasts in regulations, sources, and applications of stem cells across borders. From the highly regulated environment in the U.S. to the broader, less r...
In the premiere episode of Stem Cell Genius, host Samantha sits down with R3 Stem Cell Founder & CEO Dr. David Greene to break down two of the most talked-about topics in regenerative medicine: stem cells and exosomes. What exactly are stem cells? Are exosomes just hype or truly healing? And what are the different types of stem cells — and why does it matter? Together, Samantha and Dr. Greene unpack the science, clear up common misconceptions, and set the stage for future deep dives into ...
Stem Cell Genius
In this episode of Stem Cell Genius, Samantha Brechner, President of R3 Stem Cell, sits down with the visionary Founder and CEO of R3 Stem Cell, Dr. David Greene, to explore one of the most important questions in regenerative medicine — How do stem cells differ in the United States compared to international use? Together, they dive into the contrasts in regulations, sources, and applications of stem cells across borders. From the highly regulated environment in the U.S. to the broader, less r...